Total Payments
$4,338
2024 Payments
$438.53
Companies
25
Transactions
234
Medicare Patients
19,978
Medicare Billing
$1.7M
Payment Breakdown by Category
Food & Beverage$4,279 (98.7%)
Education$58.13 (1.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,279 | 229 | 98.7% |
| Education | $58.13 | 5 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $491.91 | 22 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $487.10 | 16 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $478.55 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $347.08 | 24 | $0 (2022) |
| PFIZER INC. | $331.49 | 27 | $0 (2023) |
| Philips Electronics North America Corporation | $272.32 | 9 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $231.13 | 14 | $0 (2024) |
| Boston Scientific Corporation | $206.10 | 12 | $0 (2023) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $202.81 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $179.34 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $438.53 | 23 | Novartis Pharmaceuticals Corporation ($178.92) |
| 2023 | $583.52 | 30 | CVRx, Inc. ($136.68) |
| 2022 | $1,098 | 58 | Bayer HealthCare Pharmaceuticals Inc. ($279.42) |
| 2021 | $773.67 | 40 | Bayer HealthCare Pharmaceuticals Inc. ($147.84) |
| 2020 | $381.51 | 16 | SANOFI-AVENTIS U.S. LLC ($145.74) |
| 2019 | $221.47 | 15 | Boston Scientific Corporation ($42.68) |
| 2018 | $310.21 | 20 | AstraZeneca Pharmaceuticals LP ($63.82) |
| 2017 | $530.90 | 32 | Novartis Pharmaceuticals Corporation ($100.39) |
All Payment Transactions
234 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/14/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $21.60 | General |
| Category: Medical Device | ||||||
| 11/04/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.53 | General |
| Category: DIABETES | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $29.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/10/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.09 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 08/28/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $3.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/27/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $17.14 | General |
| Category: Medical Device | ||||||
| 08/27/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $16.62 | General |
| Category: Medical Device | ||||||
| 08/19/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.79 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/24/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $18.44 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 07/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: DIABETES | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $3.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/16/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $25.94 | General |
| Category: Not Applicable | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/09/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 03/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $14.98 | General |
| Category: Cardiology | ||||||
| 03/19/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 02/20/2024 | Philips North America LLC | (CK7) Extended Holter (Device) | Food and Beverage | Cash or cash equivalent | $42.10 | General |
| Category: Medical Device | ||||||
| 02/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: DIABETES | ||||||
| 02/12/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/05/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardiology | ||||||
| 11/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 29 | 4,823 | 7,381 | $1.2M | $433,357 |
| 2022 | 31 | 5,367 | 7,779 | $1.1M | $403,875 |
| 2021 | 32 | 4,855 | 7,318 | $1.1M | $447,878 |
| 2020 | 31 | 4,933 | 7,123 | $1.1M | $415,215 |
Total Patients
19,978
Total Services
29,601
Medicare Billing
$1.7M
Procedure Codes
129
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 487 | 1,372 | $351,232 | $126,479 | 36.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 362 | 400 | $157,200 | $55,485 | 35.3% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 164 | 164 | $144,976 | $53,780 | 37.1% |
| 93229 | Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | Office | 2023 | 68 | 68 | $116,688 | $42,372 | 36.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 164 | 328 | $100,400 | $28,959 | 28.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 173 | 182 | $69,342 | $25,717 | 37.1% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 1,832 | 2,463 | $20,499 | $15,654 | 76.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 77 | 77 | $34,419 | $11,822 | 34.3% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 168 | 173 | $24,393 | $8,275 | 33.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 31 | 89 | $18,334 | $8,060 | 44.0% |
| 93975 | Complete ultrasound of abdomen and pelvis artery and vein blood flow | Office | 2023 | 28 | 28 | $14,812 | $5,685 | 38.4% |
| 93244 | Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 278 | 333 | $16,317 | $5,540 | 34.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 32 | 41 | $16,359 | $5,274 | 32.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 18 | 18 | $11,178 | $4,256 | 38.1% |
| 93925 | Ultrasound of leg arteries or artery grafts | Office | 2023 | 23 | 23 | $11,063 | $4,141 | 37.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 22 | 88 | $10,824 | $3,837 | 35.4% |
| 93970 | Ultrasound study of arm or leg veins with compression and maneuvers | Office | 2023 | 29 | 29 | $10,846 | $3,607 | 33.3% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 43 | 66 | $10,758 | $3,476 | 32.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 270 | 316 | $9,164 | $3,298 | 36.0% |
| 93294 | Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | Office | 2023 | 43 | 128 | $7,808 | $2,798 | 35.8% |
| 93978 | Complete ultrasound of aorta, vena cava, groin vessels or bypass grafts | Office | 2023 | 21 | 21 | $7,602 | $2,760 | 36.3% |
| 93242 | Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | Office | 2023 | 277 | 332 | $9,296 | $2,750 | 29.6% |
| 93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | Office | 2023 | 16 | 131 | $7,074 | $2,584 | 36.5% |
| 93298 | Evaluation of cardiac rhythm monitor system, remote up to 30 days | Office | 2023 | 19 | 122 | $6,588 | $2,290 | 34.8% |
| 93228 | Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | Office | 2023 | 68 | 68 | $3,536 | $1,363 | 38.5% |
About Dr. John Puleo, M.D
Dr. John Puleo, M.D is a Cardiovascular Disease healthcare provider based in Sarasota, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/15/2005. The National Provider Identifier (NPI) number assigned to this provider is 1649262882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Puleo, M.D has received a total of $4,338 in payments from pharmaceutical and medical device companies, with $438.53 received in 2024. These payments were reported across 234 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,279).
As a Medicare-enrolled provider, Puleo has provided services to 19,978 Medicare beneficiaries, totaling 29,601 services with total Medicare billing of $1.7M. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Sarasota, FL
- Active Since 08/15/2005
- Last Updated 04/24/2020
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1649262882
Products in Payments
- Kerendia (Drug) $487.10
- MULTAQ (Drug) $352.88
- ELIQUIS (Drug) $326.65
- ENTRESTO (Drug) $283.40
- BRILINTA (Drug) $219.15
- LifeVest (Device) $202.81
- LEQVIO (Drug) $195.15
- (5050) Ext Holter (Device) $172.94
- JARDIANCE (Drug) $172.33
- Barostim Neo System (Device) $155.15
- VYNDAQEL (Drug) $151.05
- FARXIGA (Drug) $140.26
- NEXLETOL (Drug) $127.54
- XARELTO (Drug) $109.62
- WATCHMAN (Device) $102.79
- (CK7) Extended Holter (Device) $97.46
- WATCHMAN Access System (Device) $90.92
- PRALUENT ALIROCUMAB INJECTION (Biological) $88.62
- (5044) MCOT (Device) $85.67
- Repatha (Biological) $78.14
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Sarasota
Dr. Mahfouz El Shahawy, Md, MD
Cardiovascular Disease — Payments: $135,512
Cardiovascular Disease $135,512
Hakim Morsli, Md, MD
Cardiovascular Disease — Payments: $120,552
Cardiovascular Disease $120,552
Dr. Elmer Arne, D.o, D.O
Cardiovascular Disease — Payments: $113,478
Cardiovascular Disease $113,478
Dr. Mark Ramos, M.d, M.D
Cardiovascular Disease — Payments: $76,653
Cardiovascular Disease $76,653
Smriti Banthia, M.d, M.D
Cardiovascular Disease — Payments: $31,106
Cardiovascular Disease $31,106
Edward Bermudez, M.d, M.D
Cardiovascular Disease — Payments: $11,024
Cardiovascular Disease $11,024